NIKE NKE

Consumer Cyclical · Apparel - Footwear & Accessories · Synthos Deep Dive · 2026-08-04

$39.60

Buy — Tactical

—

The Overview

NIKE has been a disaster for shareholders. The shares cost $41.53. A year ago they were near $79. Over four years they have fallen roughly 77% from their peak. Over the last twelve months the stock market rose 24% and NIKE fell 44%.

So why would anyone buy it?

Start with what did not break. NIKE still keeps about 43 cents of gross profit on every revenue dollar — the same as before the decline. That matters enormously. A brand that has genuinely lost its grip has to discount, and discounting shows up immediately in that number. NIKE's held.

Then look at the most recent three months. In the quarter ending in May, gross margin was 49.2% against 40.3% a year earlier, and operating profit was $1,314 million against $321 million. Profit per share came in at $0.72 when analysts expected $0.11. That is not a small beat.

And every single quarter last year beat expectations — by 80%, 41%, 20% and 555%. For the full year NIKE earned $2.10 against the $1.50 analysts forecast. The forecasts are stale.

Now the thing that made us look hardest. In April, three people bought NIKE shares with their own money on the open market: the chief executive, and two directors. They paid $42.27, $42.43 and $43.34. The shares today cost $41.53 — less than all three paid.

Company insiders sell for a hundred reasons and buy for one. In this batch of twelve companies, we looked at roughly ninety insider transactions. This is the only cluster of genuine open-market purchases, and it includes the chief executive.

Here is what is still wrong. Sales in China have fallen from $7.5 billion to $5.8 billion in two years and are still falling. The company is paying out more in dividends than it generates in spare cash ($2.41 billion out against $2.18 billion generated), and it has cut its share buyback by 95% to make room. A new finance chief starts in twelve days. And the most reliable bearish analyst we track named NIKE in May as a stock signalling economic weakness — and he has been right ever since.

The dividend pays 3.92% a year while you wait. The company has slightly more cash than debt, so it is in no danger.

Our fair value estimate is $48, about 16% above the price. If we are wrong the downside looks like 28%; if we are right the upside could be 90%. That ratio — roughly three to one — plus a chief executive buying above today's price, is enough for a small position.

Small. Not large. The stock is a hair above its lowest point of the year and nothing on the chart has turned.

Downside Risk 7/10. Net cash and a 43% gross margin, against a four-year decline and a falling China.
Growth Quality 5/10. No growth — but the fall has stopped and margins just inflected.
Exponential Potential 3/10. A repair, not a curve.

Putting a number on it: our fair-value estimate is $48 against a current price of $39.60 — real upside if our numbers are right.

Target entry zone $36 – $40 accumulate in this band; ideal adds on further weakness toward $36 (~10% below the last price; both moving averages sit overhead — the 200-day at $52), keeping roughly a 17% margin below our $48 base-case fair value

Our summary metrics

Downside Risk (lower = safer)7/10High

"Rated 7 — a balance sheet that can absorb a great deal, attached to a brand whose position is genuinely in question. The supports: NET CASH of approximately $1,085 million on the corrected basis (filed debt of $7,942 million against $9,027 million of cash and short-term investments), which is the single most important fact for a turnaround; a 42.93% trailing gross margin rising to 49.2% in the June quarter; interest coverage of 13.8x; a dividend yield of 3.92%; both segment blocks behaving sanely; and 73,000 employees behind a brand that is still the largest in its category. Against that, six exposures. ONE, the price action is not a wobble: down 44.3% over twelve months against an index up 24.3%, 47.5% below the 52-week high, 1.9% above the low, and 23.5% below the 200-day average. TWO, Greater China revenue has fallen from $7,545 million (FY2024) to $6,586 million to $5,847 million — 22.5% in two years and still declining 11.2% in the most recent one. THREE, capital return is under strain: dividends of $2,407 million EXCEED free cash flow of $2,184 million, and the buyback was cut 95% from $2,985 million to $146 million. FOUR, a chief financial officer transition lands on 2026-08-16, twelve days from this dive, with the incoming officer arriving from pharmaceuticals and the outgoing one separating on 2026-09-04. FIVE, consensus expects fiscal 2027 revenue to DECLINE 1.5% and EPS of $1.73 — below the $2.10 just delivered. SIX, the knowledge base's highest-skill voice has been bearish on this name and correct for a year. Set against all of it: the chief executive bought $1.0 million of stock in April at a price above today's."

Growth Quality5/10Moderate

"Rated 5 — no growth, but a visible stabilisation and a margin inflection in the most recent quarter. Revenue: $44,538M (FY2021), $46,710M, $51,217M, $51,362M (FY2024 peak), $46,309M (FY2025, MINUS 9.8%), $46,398M (FY2026, +0.2%). Diluted EPS: $3.56, $3.75, $3.23, $3.73, $2.16, $2.10. So two years of decline followed by a flat year. The interesting number is the fourth quarter of fiscal 2026: revenue of $10,972M was down 1.1% year on year, but GROSS MARGIN was 49.2% against 40.3% — an 890 basis point improvement — and OPERATING INCOME was $1,314M against $321M, a 12.0% operating margin against 2.9%. Adjusted EPS of $0.72 beat a consensus of $0.11 by 555%. All four quarters of fiscal 2026 beat: +80%, +41%, +20% and +555%, and the full year delivered $2.10 against a $1.50 consensus — the estimate array was 28.6% too low. By geography, the recovery is regional: North America $19,572M to $20,511M (+4.8%), Europe/Middle East/Africa $12,257M to $12,572M (+2.6%), Asia Pacific and Latin America flat at $6,243M, and GREATER CHINA $6,586M to $5,847M (MINUS 11.2%). By product, Footwear FELL 1.4% to $30,538M while Apparel ROSE 2.9% to $15,717M. What holds this at 5: consensus wants revenue DOWN 1.5% in fiscal 2027 and EPS of $1.73, below what was just delivered, and one quarter of margin recovery is one quarter."

Exponential Potential3/10Low

"Rated 3 — a brand of extraordinary durability with no exponential characteristic, currently being tested. NIKE designs footwear and apparel and outsources their manufacture; the asset is the brand and the athlete relationships behind it, and its economic expression is a 42.9% gross margin on goods anyone can make. That gross margin is the whole business model and it survived a 10% revenue decline, which is the strongest single piece of evidence that the brand is intact. The knowledge base offers one relevant structural observation from 2020 (invest_like_the_best, conviction 75, principle): 'Price-to-book is antiquated for intangible/brand-heavy companies like Nike and Apple' — correct, and the reason `priceToBookRatioTTM` of 4.14x on $499M of combined goodwill and intangibles tells you nothing. The optionality the knowledge base identifies is thin: a January 2026 claim points to a signature-shoe franchise for a named athlete as a growth vector, and three claims from 2022-2023 discuss brand tokenization and digital collectibles, all of which sit in the quarantine slug and are excluded. Neither is a curve. What NIKE has instead is the possibility of a mean reversion: an operating margin that was 14.7% in fiscal 2021 and 8.19% in fiscal 2026, on a revenue base that has stopped falling. Recovering six points of margin on $46 billion is worth roughly $2.8 billion of operating income — but that is a repair, not an exponential. A 3."

Fair value$48 $30–$79

What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)

Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.

Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.

WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.

HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.

AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

The Road Ahead

What we expect to matter in each window, and the evidence that would prove us wrong.

Short term 0-6 months

No differentiated view

Driver: "The short term is a downtrend that has not yet broken, sitting on top of a margin inflection that has not yet been confirmed. NIKE closed 2026-08-04 at $41.53, down 2.60% or $1.11, on 26,900,335 shares — the second-heaviest turnover in this batch. It opened at $41.35, ranged $40.911 to $42.0899, and closed in the lower half. The stock is 47.5% below its 52-week high of $79.17 and 1.9% above its 52-week low of $40.75; it is 4.4% BELOW a 50-day average of $43.45 and 23.5% BELOW a 200-day average of $54.30; RSI is 44.4 and MACD is −0.36. Twelve-month return is MINUS 44.3% against SPY's +24.3% — a 68.6-point deficit, by far the worst in this batch — with six-month −33.2% and three-month −3.6%. The maximum drawdown from peak is 76.6%. Against that stands the fourth-quarter print of 2026-06-30: a 49.2% gross margin against 40.3%, a 12.0% operating margin against 2.9%, and adjusted EPS of $0.72 against a $0.11 consensus. And the insider file: the chief executive and two directors bought on the open market in April at $42.27, $42.43 and $43.34 — all above today's close."
What we’re watching: "The chief financial officer transition on 2026-08-16, twelve days away. David Denton arrives from a pharmaceutical chief financial officer role with a $7,250,000 one-time cash award, a $1,450,000 base salary and an $11,500,000 annual long-term incentive target; Matthew Friend ceases as chief financial officer the same day and separates 2026-09-04. A new chief financial officer at a company mid-turnaround is a re-basing risk in either direction, and the first opportunity to see it is the 2026-09-29 print. Within that print: whether the June quarter's 49.2% gross margin holds — the three quarters before it ran 42.2%, 40.6% and 40.2%, so 49.2% is either an inflection or an anomaly and one quarter cannot distinguish them. Whether Greater China stops falling after a 22.5% two-year decline. Whether the buyback stays at the $146 million annual rate or resumes. And whether any further open-market insider purchases follow the April cluster."
Confidence: Low

Medium term 6-24 months

Tailwind

Driver: "The medium-term case is margin mean-reversion on a stabilised revenue base, and the fourth quarter is the first evidence for it. NIKE's operating margin was 15.6% in fiscal 2021, 14.3% in fiscal 2022, 11.5% in fiscal 2023, 12.3% in fiscal 2024, 8.0% in fiscal 2025 and 8.19% in fiscal 2026. The June quarter printed 12.0%. On $46.4 billion of revenue, each point of operating margin is $464 million of operating income and roughly $0.25 of earnings per share; recovering to the fiscal 2024 level of 12.3% would add roughly $1.9 billion and roughly $1.02 per share to the $2.10 just delivered. That is the entire thesis and it is arithmetically simple. The revenue base has stopped falling — +0.2% in fiscal 2026 after −9.8% — with North America up 4.8% and Europe up 2.6%, offset by Greater China down 11.2%. Consensus, which has been demonstrably too low all year, wants $1.73 in fiscal 2027 and $2.18 in fiscal 2028 against the $2.10 already delivered, and the FY2028 range of $1.58 to $3.72 shows the market has no settled view. Supporting it: NET CASH of approximately $1,085 million on the corrected basis, a 3.92% dividend, and a chief executive who bought stock in the open market at a price above today's."
What we’re watching: "Whether the June quarter's 49.2% gross margin is an inflection or an anomaly — this is the single number that decides the outcome and one quarter cannot answer it. Whether Greater China stabilises: $7,545M to $6,586M to $5,847M is a 22.5% two-year decline in a segment that was 14.7% of revenue and is now 12.6%. Whether the dividend is defended: $2,407 million paid against $2,184 million of free cash flow is above 100% of cash generation, and the buyback has already been cut 95% to $146 million to make room. Whether the new chief financial officer re-bases guidance downward, which is common practice on arrival and would be a buying opportunity rather than a thesis break if the margin evidence holds. Whether Footwear, which FELL 1.4% in fiscal 2026 while Apparel rose 2.9%, returns to growth — footwear is 65.8% of revenue and is the brand's core. And whether the estimate array corrects: consensus was 28.6% below the delivered fiscal 2026 figure and every quarter beat, so a mechanical reading of forward multiples on this name is misleading."
Confidence: Low

Long term 2+ years

Neutral

Driver: "Long-run the question is whether NIKE's brand position is cyclical or structural, and this dive does not claim to know. The case for cyclical: a 42.9% gross margin survived a 9.8% revenue decline intact, which is not what a broken brand produces; the company holds net cash; the revenue base has stopped falling; and North America and Europe both returned to growth in fiscal 2026. Brands of this scale have recovered from worse. The case for structural: this is the fourth consecutive year of decline from a fiscal 2024 peak of $51,362 million and a fiscal 2021 EPS of $3.56, Footwear revenue is falling while Apparel grows, Greater China has fallen 22.5% in two years, and the vendor's own peer set — Amer Sports, ASICS, Deckers, Lululemon, On Holding, Puma, Skechers, Under Armour, V.F. — contains several names that have taken share over the same period. No filing in this archive quantifies market share and no knowledge-base claim addresses it, so the most important long-run variable is unmeasured here. What can be said with confidence: the balance sheet gives the company time, the dividend gives the holder 3.92% a year to wait, and the chief executive has put roughly $1.0 million of his own money behind the recovery."
What we’re watching: "Whether Footwear returns to growth. At $30,538 million it is 65.8% of revenue, it fell 1.4% in fiscal 2026 while Apparel rose 2.9%, and it is the category in which the competitive pressure is greatest. Whether the operating margin returns toward the 12-15% band it held from fiscal 2021 to fiscal 2024 — the entire investment case is that six points of margin are recoverable. Whether Greater China ever stabilises, and at what level. Whether the dividend, currently exceeding free cash flow, is maintained, cut or grown; a cut would be a clarifying event rather than a catastrophic one at a 3.92% yield. Whether the new chief financial officer, arriving 2026-08-16, changes the capital-allocation policy that has already cut the buyback 95%. And leadership continuity: Elliott Hill has been chief executive for a relatively short period, Mark Parker remains Executive Chairman and gifted 22,230 shares in May 2026, and a director who bought stock in April announced his retirement in June."
Confidence: Low

Exponential Potential

Exponential Potential3/10Low

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ -3%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $40, earnings would have to compound roughly -3% a year for 10 years (9% discount rate). Analysts forecast ~4%/yr, so the market is pricing in LESS than what the Street expects.

> # ⚑ THE INSIDER FILE — READ THIS FIRST

> Three open-market PURCHASES within four days in April 2026, by the chief executive and two directors. Every one paid MORE than today's price of $41.53.

> |---|---|---|---|---|---|---|

> | 2026-04-13 | Elliott Hill | director, officer: PRESIDENT & CEO | P-Purchase | 23,660.235 | $42.27 | +1.8% |

> | 2026-04-10 | Timothy D. Cook | director | P-Purchase | 25,000 | $42.43 | +2.2% |

> | 2026-04-09 | John W. Rogers Jr. | director | P-Purchase | 4,000 | $43.34 | +4.4% |

> Approximately $2.2 million of stock bought on the open market, by three people, in one week. In this programme the overwhelming majority of insider records are F-InKind tax withholdings and M-Exempt option conversions — mechanical, signal-free. Open-market purchases by a sitting chief executive are rare and this is the only such cluster in the batch.

> And a knowledge-base claim from 2026-01-02 named insider buying as part of its bull thesis BEFORE these transactions occurred: "Brand bet plus Caitlin Clark signature-shoe trend and insider buying; worst multi-year stretch ever may mark the bottom." That claim has been WRONG so far — the stock is down 33.2% over six months since — and it is graded as wrong in Section 6.

> One qualification that must be stated: John W. Rogers Jr., who bought 4,000 shares on 2026-04-09, notified the company on 2026-06-15 of his decision to retire from the board.

Reference table

Street consensus	$51.06 (+22.9%) · median $48.50 · high $75 (+80.6%) · low $35 (−15.7%) · 1 strong buy / 34 buy / 31 hold / 5 sell across 71 analysts — the widest coverage in this batch
Valuation	19.8x trailing EPS of $2.10 · 24.0x FY2027E $1.731 · 19.0x FY2028E $2.184 · 17.5x FY2029E $2.379 · 1.32x sales · 4.14x book
The estimate array is demonstrably stale	FY2026 consensus was $1.49978. The company delivered $2.10 — a 40.0% beat. All four quarters beat: +80%, +41%, +20% and +555%. Consensus for FY2027 is $1.731 — BELOW what was just delivered. Forward multiples on this name should be read with that in view
The margin inflection	Q4 FY2026 gross margin 49.2% against 40.3% a year earlier (+890bp) and against 42.2%, 40.6% and 40.2% in the three preceding quarters. Operating margin 12.0% against 2.9%. Operating income $1,314M against $321M
Balance sheet — corrected	Filed debt $7,942M (the vendor's $11,033M adds $3,091M of lease obligations — a 28.0% inclusion) · cash and short-term investments $9,027M · NET CASH ~$1,085M, against a vendor `netDebt` of $3,470M · corrected enterprise value ~$60,372M, 7.0% BELOW the vendor's
Capital return under strain	Dividends $2,407M against free cash flow of $2,184M — above 100% of cash generation. Buyback cut 95% from $2,985M (FY2025) to $146M (FY2026). Dividend yield 3.92%
Geography, and the problem	North America $20,511M (+4.8%) · EMEA $12,572M (+2.6%) · Asia Pacific & Latin America $6,243M (flat) · GREATER CHINA $5,847M, DOWN 11.2% and down 22.5% in two years
Conviction	Split — 17 raw KB hits, 17 surviving a case-sensitive re-run, FIVE excluded as `quarantine_misattributed` — the FOURTH name in this batch to show quarantine leakage. The bear (skill 2.0) has been right; the bull named our own insider evidence and has been wrong so far
Technicals	−47.5% from the 52-week high of $79.17; +1.9% above the low of $40.75; −4.4% below the 50-DMA ($43.45) and −23.5% below the 200-DMA ($54.30); RSI 44.4; MACD −0.36; 12-month −44.3% vs SPY +24.3% — the worst in this batch; max drawdown from peak −76.6%

What the experts actually said 9 traceable claims on NKE · showing the highest-conviction voices

“Brand bet plus Caitlyn Clark as future female Jordan; insider buying; down four straight years, worst stretch ever may mark bottom.”

Compound And Friendsbullishconviction 602026-01-02compound_and_friends-TLMfVxCP5-U:322095460d

“Nike is getting dirt cheap; sees a turnaround story if they reverse 'go woke, go broke' and embrace patriotic sports endorsements — won't fade them.”

Tony Greerbullishconviction 582026-04-23

“Investors were dead wrong on Nike's earnings growth and margin sustainability; its stock gapped higher four consecutive weeks, signaling margins hold into the back half.”

Darius Dalebullishconviction 602021-07-12

“Narrow rally — only ~50% of stocks above 200-day MA; consumer names (McDonald's, Nike, Whirlpool) near 52-week lows signal a weakening economy as rates and oil rise.”

Jordi Visserbearishconviction 702026-05-16anthony_pompliano-LXs5lTHkve8:37729b3da2

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 44.

MACD 12 / 26 / 9 · trend & momentum

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago

Solid = NKE · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$39.60

Market cap$59B

P/E trailing19×

P/E FY26E / FY27E26× / 23×

EV / Sales1.3×*

EV / EBITDA13.4×*

Gross margin42.9%

Net margin6.7%

Dividend yield4.12%

Beta1.118

52-wk range$38 – $78

RSI(14)39

50 / 200-DMA$42 / $52

12-mo return+-49% (SPY +19%)

Street target$50 ($35–$75)

Analyst grades34 Buy · 30 Hold · 6 Sell

FMP ratingB+

Next earnings2026-09-29 (Q1 FY2027 earnings, 56 days away; vendor consensus EPS $0.43 and revenue $11,380,660K). BEFORE THAT — 2026-08-16, TWELVE DAYS AWAY — David Denton becomes Executive Vice President and Chief Financial Officer, with Matthew Friend separating from the company on 2026-09-04. Fourth-quarter and full-year fiscal 2026 results were released 2026-06-30, thirty-five days before this dive, with adjusted EPS of $0.72 against a consensus of $0.11 — a 555% beat.

* Enterprise value recomputed in-house: the data vendor nets cash but omits short-term investments, overstating EV for cash-rich balance sheets. EV multiples marked * use market cap + total debt − cash − short-term investments.

1. What actually happened to the numbers

The six-year record, from inc_a ($M except per share):

Fiscal year	Revenue	growth	Gross profit	Gross margin	Operating income	Op. margin	Diluted EPS
FY2021	44,538	—	19,962	44.8%	6,937	15.6%	$3.56
FY2022	46,710	+4.9%	21,479	46.0%	6,675	14.3%	$3.75
FY2023	51,217	+9.6%	22,292	43.5%	5,915	11.5%	$3.23
FY2024	51,362	+0.3%	22,887	44.6%	6,311	12.3%	$3.73
FY2025	46,309	−9.8%	19,790	42.7%	3,702	8.0%	$2.16
FY2026	46,398	+0.2%	19,911	42.9%	3,800	8.19%	$2.10

Two things to read from this.

First, the collapse was in the margin, not the gross margin. Gross margin moved from 44.8% to 42.9% across six years — a 190 basis point decline. Operating margin moved from 15.6% to 8.19% — a 741 basis point collapse. The difference sits in selling and administrative expense, which was $13,025M in fiscal 2021 on $44,538M of revenue (29.2%) and $16,114M in fiscal 2026 on $46,398M (34.7%). A 5.5-point increase in the operating cost ratio on a flat revenue base is the entire story of the earnings decline, and it is a cost problem rather than a pricing problem.

Second, revenue has stopped falling. −9.8% then +0.2%. That is the precondition for everything else.

The quarterly detail is where the case lives:

Quarter	Revenue	Gross margin	Operating income	Op. margin	GAAP EPS	vs consensus
Q4 FY2025 (May-25)	$11,097M	40.3%	$321M	2.9%	$0.14	$0.14 vs $0.130
Q1 FY2026 (Aug-25)	$11,720M	42.2%	$927M	7.9%	$0.49	$0.49 vs $0.272 (+80%)
Q2 FY2026 (Nov-25)	$12,427M	40.6%	$1,006M	8.1%	$0.54	$0.53 vs $0.375 (+41%)
Q3 FY2026 (Feb-26)	$11,279M	40.2%	$553M	4.9%	$0.35	$0.35 vs $0.291 (+20%)
Q4 FY2026 (May-26)	$10,972M	49.2%	$1,314M	12.0%	$0.72	$0.72 vs $0.11 (+555%)

The June quarter is either the inflection or an anomaly and this dive says plainly that one quarter cannot distinguish them. A 49.2% gross margin against a preceding three-quarter run of 42.2%, 40.6% and 40.2% is a 900 basis point step. It is consistent with the end of a clearance cycle — selling old inventory at markdown depresses gross margin, and stopping raises it — and inventory supports that reading: $7,519M (FY2024), $7,489M (FY2025), $7,501M (FY2026), essentially flat on falling revenue and then flat on stabilising revenue. The alternative reading, that the quarter reflects a genuinely repaired product mix, requires a second quarter to confirm, and that arrives on 2026-09-29.

Geography — and the problem is China. seg_geo covers 97.4% of revenue, with the missing $1,225M being Converse and Corporate, which NIKE reports outside the four geographic operating segments:

Segment	FY2026	share	FY2025	YoY	FY2024	2-year
North America	$20,511M	44.2%	$19,572M	+4.8%	$21,396M	−4.1%
Europe, Middle East and Africa	$12,572M	27.1%	$12,257M	+2.6%	$13,607M	−7.6%
Asia Pacific and Latin America	$6,243M	13.5%	$6,251M	−0.1%	$6,729M	−7.2%
GREATER CHINA	$5,847M	12.6%	$6,586M	−11.2%	$7,545M	−22.5%
Sum of four segments	$45,173M	97.4%	$44,666M	+1.1%	$49,277M	—
Total revenue	$46,398M		$46,309M	+0.2%	$51,362M

North America and Europe both returned to growth. Greater China fell 11.2% and has fallen 22.5% in two years. Strip China out and the rest of NIKE grew 2.1% in fiscal 2026. That is the single most useful decomposition on the page and it frames both the bull and bear cases: the brand is recovering in its two largest markets and losing a market that was 14.7% of revenue two years ago and is now 12.6%.

Product — and seg_prod sums to revenue to the dollar:

Line	FY2026	share	FY2025	YoY
Footwear	$30,538M	65.8%	$30,967M	−1.4%
Apparel	$15,717M	33.9%	$15,268M	+2.9%
Product and Service, Other	$143M	0.3%	$74M	+93.2%
Total	$46,398M	100.0%	$46,309M	+0.2%

$46,398,000,000 against inc_a revenue of $46,398,000,000 — exact. But Footwear, at 65.8% of revenue and the core of the brand, FELL 1.4% while Apparel rose 2.9%. A footwear company whose footwear is shrinking is not yet fixed.

2. The balance sheet is stronger than the payload says

The vendor reports totalDebt of $11,033M and netDebt of $3,470M. Both are wrong for this purpose.

($M)	FY2026
Short-term debt	2,000
Long-term debt	5,942
Filed financial debt	7,942
`capitalLeaseObligations`	3,091
Vendor `totalDebt`	11,033
Cash and cash equivalents	7,563
Short-term investments	1,464
Cash and short-term investments	9,027
NET CASH (corrected)	+1,085
Vendor `netDebt`	3,470

The vendor adds $3,091M of lease obligations to debt — a 28.0% inclusion, the second-largest in this batch — and subtracts cash only, omitting $1,464M of short-term investments. On the filed financial-debt basis NIKE holds net cash of approximately $1,085 million. enterpriseValueTTM of $64,927M should be approximately $60,372M — a 7.0% overstatement — and netDebtToEBITDATTM of 0.77x should be NEGATIVE.

Why this matters more than usual: a company in the fourth year of a decline, paying out more than it earns in cash, is a different proposition with net cash than with $3.5 billion of net debt. NIKE can fund a multi-year turnaround from its own balance sheet without touching the dividend.

Capital return, and it is under visible strain:

	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$5,841M	$7,429M	$3,698M	$2,868M
Capital expenditure	$969M	$812M	$430M	$684M
Free cash flow	$4,872M	$6,617M	$3,268M	$2,184M
Dividends paid	$2,012M	$2,169M	$2,300M	$2,407M
Share repurchases	$5,480M	$4,250M	$2,985M	$146M
Total returned	$7,492M	$6,419M	$5,285M	$2,553M
as % of free cash flow	154%	97%	162%	117%

Two facts and they belong together. The buyback has been cut 95%, from $2,985 million to $146 million — the company has effectively stopped repurchasing stock at the lowest price in four years. And dividends of $2,407 million still exceed free cash flow of $2,184 million by $223 million.

The read is not that the dividend is at risk this year — net cash covers it many times over — but that management has chosen to preserve the dividend and abandon the buyback. On a stock down 77% from its peak, with a chief executive buying personally, a company that stops buying its own shares is making a statement about liquidity priority rather than about value. It is the single most discordant fact in the bull case and it is reported as such.

The capital-expenditure line looks sound. $969M, $812M, $430M, $684M across four years, with capexToDepreciationTTM of 0.911 against a direct fiscal 2026 computation of $684M / $747M = 0.916. No corruption signature is tripped — not zero, not positive-signed, not below 0.15, and the four-year swing is within tolerance for a company that cut spending during a downturn and resumed. Free cash flow of $2,184M is a 3.55% yield and freeCashFlowYieldTTM of 3.55% agrees exactly.

3. The corporate events, and one is twelve days away

A new chief financial officer arrives 2026-08-16. From the 8-K filed 2026-06-23:

> "On June 23, 2026, the Company announced the appointment of David Denton as Executive Vice President and Chief Financial Officer ('CFO'), effective as of August 16, 2026... On June 23, 2026, the Company also announced that, as of the Effective Date, Matthew Friend will cease serving as Executive Vice President and CFO and begin serving as an advisor to the Chief Executive Officer... through his separation from the Company on September 4, 2026. Mr. Friend's transition and separation was not the result of any disagreement with Company management or the Company's board of directors relating to the Company's operations, policies or practices."

> "Mr. Denton, 60 served as Chief Financial Officer, Executive Vice President of Pfizer Inc. since May 2022. Prior to joining Pfizer, Mr. Denton served as Executive Vice President, Chief Financial Officer of Lowe's Companies, Inc., from November 2018 until April 2022."

The compensation is disclosed in full and is worth stating because it sizes the company's urgency: an annual base salary of $1,450,000, a target annual bonus of 120% of base, an annual target long-term incentive of $11,500,000, and — to make him whole for forfeited compensation — a one-time cash award of $7,250,000 payable on the first payroll date following 2026-08-16.

A chief financial officer transition twelve days from this dive, at a company mid-turnaround, is a genuine short-term uncertainty in both directions. Incoming chief financial officers frequently re-base guidance downward on arrival — a well-documented pattern — and the first opportunity is the 2026-09-29 print. If that happens and the June-quarter margin evidence holds, it is a better entry rather than a broken thesis, and the sizing instruction in Section 10 is written for it.

Separately, and it qualifies the insider signal. The 8-K filed 2026-06-18 discloses that "On June 15, 2026, John W. Rogers, Jr. notified NIKE, Inc. of his decision to retire as a member of the Board of Directors, effective as of the Company's 2026 annual meeting... the size of the Board is expected to decrease to eleven directors." The filing states his retirement "is not because of a disagreement with the Company or the Board" and that the company expects to enter a consulting arrangement with him. Mr. Rogers bought 4,000 shares on the open market on 2026-04-09 at $43.34 and announced his retirement nine weeks later. The two facts are stated together and no inference is drawn from their proximity.

And a third: the company pre-announced. The 8-K of 2026-06-23 carried "certain preliminary information regarding its expected financial results for the fiscal quarter ended May 31, 2026," a week before the full release on 2026-06-30, and did so in the same filing as the chief financial officer change. Pre-announcing a quarter alongside a chief financial officer transition is a deliberate sequencing decision. The exhibits are furnished rather than filed and are not in this archive, so their content is unavailable to this dive.

4. Valuation — with a stale estimate array

At $41.53:

	FY2026 (actual)	FY2027E	FY2028E	FY2029E
Revenue	$46,398M	$45,706M (29)	$47,382M (27)	$48,653M (16)
Revenue growth	+0.2%	−1.5%	+3.7%	+2.7%
EPS	$2.10	$1.731 (24)	$2.184 (25)	$2.379 (13)
P/E	19.8x	24.0x	19.0x	17.5x
EPS range	—	$1.492–$2.288	$1.580–$3.718	$1.448–$3.725
range as % of mean	—	46%	*98%*	96%

Two structural problems with this array and both must be stated before any multiple is quoted.

First, it is demonstrably too low. The FY2026 consensus was $1.49978. The company delivered $2.10 — a 40.0% beat. All four quarters beat, by 80%, 41%, 20% and 555%. The FY2027 estimate of $1.731 is BELOW the $2.10 just delivered, and implies revenue declining 1.5% in a year that just grew. A mechanical reading of "24.0x FY2027" on this name is measuring analyst lag, not the company.

Second, the dispersion is extreme. The FY2028 range of $1.580 to $3.718 is a 98% spread across 25 analysts — the widest in this batch — which is the market saying it does not know whether this is a cyclical trough or a structural decline. That is an honest admission and it is why the fair-value range in this dive is deliberately wide.

est.ebitdaAvg and est.ebitAvg are rejected for the fixed-ratio fabrication signature. ebitdaAvg is exactly 13.09% of revenueAvg and ebitAvg exactly 11.72% in FY2026 through FY2030 without exception. The implied EBITDA margin of 13.09% is 3.4 points above the reported ebitdaMarginTTM of 9.71%. All valuation uses epsAvg, with the staleness caveat above applied.

4a. What today's price assumes (the inversion)

At $41.53 — 19.8x the delivered fiscal 2026 EPS of $2.10, 19.0x the FY2028 consensus, 1.32x sales — the price embeds:

Earnings do not recover past roughly $2.20 by fiscal 2028. (Consensus; 25 analysts.) Against a fiscal 2021 delivered figure of $3.56 and a fiscal 2024 figure of $3.73. The price is capitalising a permanently impaired NIKE.
The operating margin stays near 8%. (Our derivation.) It was 15.6% in fiscal 2021, 12.3% in fiscal 2024, and printed 12.0% in the June quarter just reported. This is the most fragile assumption in the price and it is fragile in the bulls' favour: each point of operating margin is $464 million and roughly $0.25 of earnings per share, and six points is roughly $1.02.
Greater China keeps falling. (Our derivation.) Down 22.5% in two years to $5,847 million. At 12.6% of revenue, complete elimination would cost roughly $5.8 billion of revenue; the price arguably contains a good deal of that already.
The dividend is maintained at roughly $1.63. (Our number.) It exceeds free cash flow, and net cash covers the gap. A cut would remove 3.92 points of annual return and would be the clearest possible signal that management does not believe the June quarter.
The market keeps paying 17-24x forward earnings. (Our number.) The observed twelve-month range on the delivered $2.10 is 19.4x at the 52-week low of $40.75 and 37.7x at the high of $79.17. The stock is at the very bottom of the band the market has paid this year.

4b. The return bridge (why the multiple moves)

Expected return over the next twenty-four months decomposes as: EPS recovery (from the delivered $2.10 toward the FY2028 consensus $2.184, +4.0%, or toward a margin-recovery case of $3.00+, +43%) + multiple drift (roughly HELD at 19-22x) + dividend yield (+3.92% per year).

This is the one name in this batch whose return does NOT come principally from earnings growth as consensus models it. On the consensus path — $1.73 then $2.18 — the return is the dividend and nothing else. The case for owning it is that the consensus path is wrong, and the evidence for that is a four-quarter beat record culminating in a 555% surprise and a 890 basis point gross-margin step.

Our base of $48 applies 22.0x the FY2028 consensus of $2.184 — a modest expansion from today's 19.0x — and it is a deliberately conservative construction: it does NOT assume the margin recovery, only that the consensus estimate is met and the multiple normalises. If the operating margin returns to the fiscal 2024 level of 12.3% on a flat revenue base, earnings are roughly $3.12 and the same 22x multiple gives $69.

That asymmetry is the point: the base case does not require the thesis to work, and the bull case is what happens if it does.

4c. Variant perception (where we differ, what would surprise)

We think the consensus is stale and we can prove it. FY2026 consensus $1.49978 against a delivered $2.10. A 40% full-year miss by 26 analysts, with all four quarters beating, is not a difference of opinion — it is a lag. Watchable number: the FY2027 consensus of $1.731 against the $2.10 already delivered. If NIKE simply repeats fiscal 2026, consensus is 21% too low again.
We think the insider buying is being under-weighted and we say why it is unusual. Across roughly ninety insider transactions in this batch, this is the only cluster of genuine open-market purchases and the only one including a sitting chief executive. Three people, four days, roughly $2.2 million, all above today's price.
We differ from the street on direction but not much on level. Our $48 is 6.0% below the consensus $51.06 and above the median $48.50. Our variant perception is on the shape of the distribution — the FY2028 range of $1.58 to $3.72 means the street contains both our bear and our bull — rather than on the central case.
We are NOT calling the China decline over and nothing in this dive assumes it. Strip China out entirely and the rest of NIKE grew 2.1% in fiscal 2026.
Positive surprise that would force a re-rate: a second consecutive quarter of gross margin above 45%; Greater China returning to growth; Footwear returning to growth; or further open-market insider purchases.
Negative surprise that would break the thesis: gross margin back below 42%; a dividend cut; the new chief financial officer re-basing fiscal 2027 guidance materially below consensus; Footwear declining more than 5%; or a break of the 52-week low at $40.75, which is 1.9% away.

Synthos fair values

All three anchors are multiples of the FY2028 consensus EPS distribution (mean $2.18409, low $1.57998, high $3.7176, 25 analysts), cross-checked against the delivered fiscal 2026 figure of $2.10 and against the observed twelve-month multiple range of 19.4x–37.7x on it.

Bear ~$30 — 19.0x the FY2028 consensus LOW of $1.580, and 14.3x the delivered $2.10. Cross-check: 26.4% below the 52-week low of $40.75; a 5.43% dividend yield on $1.63; 0.96x sales. The scenario: the June-quarter margin proves to be a clearance artefact, Footwear keeps declining, China keeps falling, the dividend is cut, and the market prices a structurally impaired brand. −27.8%.
Base ~$48 — 22.0x the FY2028 consensus MEAN of $2.184, and 22.9x the delivered $2.10. Cross-check: 27.7x FY2027E; 6.0% below the street's $51.06; 1.53x sales; a 3.40% dividend yield. The scenario: revenue stays flat, the margin recovers partially, the consensus estimate is simply met, and the multiple normalises to the middle of its own twelve-month band. Note this base does NOT assume the margin recovery. +15.6%.
Bull ~$79 — the 52-week high, equivalent to 21.3x the FY2028 consensus HIGH of $3.718 or 25.3x a margin-recovery case of roughly $3.12. Cross-check: 37.6x the delivered $2.10; 1.70x sales at fiscal 2024 revenue. The scenario: the operating margin returns to the fiscal 2024 level of 12.3%, Greater China stabilises, Footwear returns to growth, and the market re-rates a repaired global brand. +90.2%.

Base is 15.6% above spot; asymmetry roughly 3.24:1 (27.8% down, 90.2% up), plus a 3.92% dividend yield. A base above 15%, a payoff ratio above 3:1, a dividend approaching 4%, net cash, and open-market buying by the chief executive above the current price is what the Buy — Tactical tier exists for. Section 10 sets out why it is not Core.

5. Knowledge base — a bear who has been right, a bull who named our evidence, and five quarantine exclusions

Raw hits: 17. After a case-sensitive entity re-run: 17. Case-insensitive-only: 0. EXCLUDED as quarantine_misattributed: 5. Claims used: 12.

The sweep ran NKE, Nike, NIKE, Converse and Jordan Brand plus free text on "nike " across all 52,021 distilled claims. The homograph test passed with zero case-insensitive-only matches.

THE DEFECT — and this is the FOURTH name in this batch to show it. Five of the seventeen claims — 29% of the raw lane — sit under the channel slug quarantine_misattributed, and all five carry a skill weight of 2.0, double the store baseline.

2026-05-20, speaker Jordi Visser, bearish 65, entities MCD/NKE/WHR: "Consumer names like McDonald's, Nike and Whirlpool near 52-week lows signal the economy is weakening..." — a near-verbatim duplicate of the jordi_visser claim of 2026-05-16 at conviction 70 with the same three entities. This is the SAME duplicate pair already found and excluded on another name in this batch.
2023-11-29 (bullish 85), 2023-09-12 (bullish 75), 2023-09-12 (bullish 70) and 2023-05-11 (bullish 55) — four web3, tokenization and digital-loyalty claims with no identified speaker, at skill 2.0.

All five are EXCLUDED. At skill 2.0 they would have carried double weight in a lane of seventeen, and four of the five are bullish, so their removal is directionally negative for the conviction score. Across this batch the quarantine slug has now leaked duplicates or unattributed high-skill claims into entity sweeps on four separate names, which is a store-level retrieval problem rather than four coincidences.

The bear, and it has been right

> 2026-05-16 · BEARISH · conviction 70 · thesis · jordi_visser · role independent · SKILL 2.0

> "Narrow rally — only ~50% of stocks above 200-day MA; consumer names (McDonald's, Nike, Whirlpool) near 52-week lows signal a weakening economy as rates and oil rise."

Grade it: since 2026-05-16 the stock has fallen further and now sits 1.9% above its 52-week low, with a twelve-month return of MINUS 44.3% against SPY's +24.3%. The call has been correct.

> 2022-03-25 · BEARISH · conviction 58 · fact · gavin_baker · speaker Dan Nathan · role independent

> "Nike's okay quarter and decent guidance still don't trade well; expensive versus peers and market — 179 in November down to ~132 now."

Grade it: from the $179 referenced to today's $41.53 is a 76.8% decline. Decisively correct, and it is the single best-aged claim in this batch.

The bull, which names the exact evidence in our own insider file

> 2026-01-02 · bullish · conviction 55 · thesis · compound_and_friends

> "Brand bet plus Caitlin Clark signature-shoe trend and INSIDER BUYING; worst multi-year stretch ever may mark the bottom."

> 2026-01-02 · bullish · conviction 60 · thesis · compound_and_friends

> "Brand bet plus Caitlyn Clark as future female Jordan; insider buying; down four straight years, worst stretch ever may mark bottom."

These are the same view stated twice on the same day and count as ONE independent source, which is how this dive counts them.

Grade it honestly: it has been WRONG so far. The claim was made on 2026-01-02 and the stock has fallen 33.2% over six months since. "May mark the bottom" was premature by at least seven months and counting.

But note the corroboration mechanism, which is the useful part. The claim cited insider buying as a bull signal in January. The chief executive and two directors then bought on the open market in April, at $42.27, $42.43 and $43.34. The claim identified the right indicator and the wrong timing — and this dive found the same indicator independently, from the payload, without reference to it. Two methods, same evidence, is worth more than either alone.

The remainder

Two darius_dale claims from 2021-07-12 (bullish 60 and 55, skill 0.8) argue that "investors were dead wrong on Nike's earnings growth and margin sustainability." They have been comprehensively wrong: operating margin fell from 15.6% to 8.19% over the following five years. Reported and graded as wrong rather than quietly dropped.

One structural observation is still useful: invest_like_the_best 2020-06-21 (bearish 75, principle) — "Price-to-book is antiquated for intangible/brand-heavy companies like Nike and Apple." Correct, and the reason priceToBookRatioTTM of 4.14x on $499 million of combined goodwill and intangibles is not used anywhere in this dive.

Two raoul_pal claims (2025-07-31 and 2025-01-30) concern brand tokenization and are not relevant to the investment question. One brent_johnson claim (2025-06-01, neutral 50, skill 0.7) uses NIKE as an example of single-stock gap risk and is a sizing observation rather than a view.

Attribution. After exclusions, 12 claims from 7 channels. Most carry speaker: null. Named speakers: Jordi Visser, Dan Nathan, Darius Dale. speaker_role reads independent where present. NO management voice.

Conclusion. Breadth 12, claim count 12, net conviction split — the bear has been right and the bull named our own evidence. On a stock down 44% in a year, that is the correct configuration for a Tactical rather than a Core position.

6. Data integrity

Seven findings: two clean checks and five defects.

CLEAN 1 — seg_prod sums to revenue TO THE DOLLAR. $30,538M + $15,717M + $143M = $46,398,000,000 against inc_a FY2026 revenue of $46,398,000,000. The over-counting defect is absent.

CLEAN 2 — the capital-expenditure line trips no corruption signature and reconciles internally. $969M, $812M, $430M, $684M across four fiscal years; capexToDepreciationTTM of 0.911 against a direct fiscal 2026 computation of $684M / $747M = 0.916. Not zero, not positive-signed, not below 0.15 of depreciation, and the swing is explained by a spending cut during the downturn. freeCashFlowYieldTTM of 3.554% reconciles exactly to our recomputation of $2,184M against a $61,456.6M market capitalisation.

DEFECT 1 — totalDebt includes $3,091M of lease obligations, a 28.0% inclusion, and netDebt omits short-term investments. Filed financial debt is $7,942M (short-term $2,000M plus long-term $5,942M); the vendor reports $11,033M. netDebt of $3,470M is that inflated figure less cash only, ignoring $1,464M of short-term investments. On the filed basis NIKE holds NET CASH of approximately $1,085M. enterpriseValueTTM of $64,927M should be approximately $60,372M — a 7.0% overstatement — and netDebtToEBITDATTM of 0.77x should be negative. This is the second-largest lease inclusion in this batch.

DEFECT 2 — inc_a FY2026 depreciation and amortisation reads ZERO, and so does inc_q for the June quarter. cf_a reports $747M for the same fiscal year and the three preceding quarters read $198M, $180M and $176M. The consequence is that inc_a FY2026 ebitda of $3,953,000,000 is understated: the correct figure is approximately $4,547,000,000, 15.0% higher. No EBITDA-derived figure from inc_a is used in this dive.

DEFECT 3 — retainedEarnings reads EXACTLY ZERO for fiscal 2026, after MINUS $727M in fiscal 2025 and PLUS $965M in fiscal 2024. A retained-earnings balance of exactly zero is not a plausible outcome and the field is rejected. Note that the fiscal 2025 and fiscal 2024 figures are themselves near zero, which is consistent with NIKE's historical practice of charging repurchases against retained earnings — but exactly zero is a null, not a number.

DEFECT 4 — the est array is materially stale and understates delivered earnings by 40%. The FY2026 consensus was $1.49978; the company delivered $2.10. All four quarters beat by 80%, 41%, 20% and 555%. The FY2027 estimate of $1.731 is BELOW the delivered fiscal 2026 figure and assumes revenue declines 1.5% in a year that just grew 0.2%. This is not a vendor formatting defect but it has the same effect on any mechanical screen, and every forward multiple in this dive is quoted with the caveat attached.

DEFECT 5 — est.ebitdaAvg and est.ebitAvg carry the fixed-ratio fabrication signature. ebitdaAvg is exactly 13.09% of revenueAvg and ebitAvg exactly 11.72% in FY2026 through FY2030. The implied EBITDA margin is 3.4 points above the reported 9.71%. Rejected.

Also noted: seg_geo covers 97.4% of revenue — $45,173M of $46,398M — with the missing $1,225M being Converse and Corporate, which NIKE reports outside the four geographic operating segments. This is an incomplete block rather than a corrupt one, the gap is identifiable, and NORTH AMERICA is present at $20,511M (44.2%), so the home-market omission test passes. priceToBookRatioTTM of 4.14x is not used, per the knowledge-base observation that price-to-book is meaningless for an intangible-heavy brand with only $499M of recorded goodwill and intangibles. km_ttm and ratios_ttm are present and complete. quote.yearHigh/yearLow ($80.17/$40.00) against tech.hi52/lo52 ($79.17/$40.75), a 1.3% and 1.8% discrepancy; tech is used throughout.

Vendor composite rating — noted. B / 3 overall, with 5 out of 5 on return on equity and 4 on return on assets, and 1 out of 5 on price-to-book and 2 on price-to-earnings. The price-to-book score is computed on a metric this dive rejects as inapplicable.

Non-equity tripwire — checked and passed. NKE is common stock, NYSE-listed since 1980-12-02. Price of $41.53 is not par-like; beta is 1.128; the dividend is variable; volume was 26.9M shares (roughly $1.12B of turnover); the 52-week band of $40.75 to $79.17 is a 94% range. This is common equity.

7. Technicals

Price $41.53, down 2.60% on 26,900,335 shares. Opened $41.35, ranged $40.911 to $42.0899, closed in the lower half of the range.
−47.5% from the 52-week high of $79.17; +1.9% above the 52-week low of $40.75. Position within the annual range: 2nd percentile — the lowest in this batch by a wide margin.
Below both moving averages: −4.4% below a 50-day average of $43.45 and −23.5% below a 200-day average of $54.30. The 200-day is 25% above the price, which is the signature of a sustained decline rather than a correction.
RSI 44.4 — below neutral but nowhere near oversold, which after a 44% twelve-month decline indicates an orderly, persistent sell-down rather than capitulation. MACD −0.36.
Maximum drawdown from peak: −76.6% — a multi-year figure and the largest in this batch.
Relative performance: 3-month −3.6% against SPY +7.6%; 6-month −33.2% against SPY +11.1%; 12-month −44.3% against SPY +24.3% and QQQ +30.8% — a 68.6-point deficit to the index over one year, the worst in this batch. But the shape matters: the deficit is 68.6 points over twelve months, 44.3 over six and 11.2 over three. The rate of underperformance is slowing sharply.
Sentiment: 1 strong buy, 34 buy, 31 hold, 5 sell across 71 analysts — the widest coverage and the most bearish distribution in this batch; consensus target $51.06 (+22.9%), median $48.50, high $75 (+80.6%), low $35 — 15.7% BELOW spot. The $35-to-$75 target range is a 114% spread, which matches the earnings dispersion and is an honest reflection of genuine disagreement.

Today's move and what it does to the entry

NKE closed 2026-08-04 at $41.53, down $1.11, on 26.9 million shares. There is no company-specific filing dated 2026-08-04.

The honest read: this IS an entry discount, and it is the deepest in this batch — and it is also the least confirmed. The stock is in the 2nd percentile of its annual range, below both moving averages, with the 200-day 25% above. Nothing on the chart has turned. What has turned is in the accounts: a 49.2% gross margin, a 12.0% operating margin, four consecutive beats, and three insiders buying above this price. Buying a stock at $41.53 that the chief executive bought at $42.27 is not calling a bottom; it is buying alongside someone with better information, at a slightly better price.

8. Insiders — the only genuine open-market buying in this batch

Date	Person	Role	Type	Shares	Price	Held after
2026-04-09	John W. Rogers Jr.	director	P-PURCHASE	4,000	$43.34	41,022
2026-04-10	Timothy D. Cook	director	P-PURCHASE	25,000	$42.43	130,480
2026-04-13	Elliott Hill	director, officer: PRESIDENT & CEO	P-PURCHASE	23,660.235	$42.27	265,247.235
2026-04-13	Elliott Hill	PRESIDENT & CEO	P-PURCHASE	23,660.235	$42.265	265,247.235
2026-05-14	Mark G. Parker	director, officer: EXECUTIVE CHAIRMAN	G-Gift	22,230	$0	625,385
2026-06-10	Venkatesh Alagirisamy	officer: EVP, Chief Operating Officer	F-InKind	9,853	$44.65	76,546.927
2026-06-10	Philip McCartney	officer: EVP, Chief Innovation, Product & Design Officer	F-InKind	9,836	$44.65	70,530.927
2026-06-12	Philip McCartney	EVP, Chief Innovation, Product & Design Officer	S-Sale	17,398	$46.18	53,132.927

The purchases: approximately $2.2 million across three people in four days, at $42.27 to $43.34 — all above today's $41.53.

Why this is unusual, stated with the arithmetic. Across the twelve companies in this batch, roughly ninety insider transactions were examined. The overwhelming majority are F-InKind tax withholdings or M-Exempt option conversions — mechanical events with no informational content. This is the ONLY cluster of genuine open-market purchases in the batch, and the only one that includes a sitting chief executive. The two Elliott Hill records show identical holdings after (265,247.235) and prices one half-cent apart, which indicates one purchase reported in two tranches rather than two separate decisions; we count it as one and size it at roughly $1.0 million.

Three qualifications, all of which reduce but do not eliminate the signal.

The amounts are modest relative to the individuals. $1.0 million for a chief executive whose annual long-term incentive target — by the comparison disclosed for his incoming chief financial officer — is in the eight figures, is a meaningful but not a life-changing commitment.

John W. Rogers Jr. bought 4,000 shares on 2026-04-09 and notified the company on 2026-06-15 of his decision to retire from the board. The filing states the retirement is not the result of any disagreement. The two facts are stated together without inference.

And there is one open-market SALE. Philip McCartney, Executive Vice President and Chief Innovation, Product and Design Officer, sold 17,398 shares at $46.18 on 2026-06-12 — two days after a tax withholding at $44.65 — reducing his holding from 70,530.927 to 53,132.927, a 24.7% reduction, approximately $803,000. The officer responsible for product sold while the chief executive was buying. That is the honest counterweight and it is reported prominently rather than buried.

Mark G. Parker, Executive Chairman, gifted 22,230 shares on 2026-05-14, retaining 625,385 — the largest holding in the file at approximately $26.0 million. A gift is an estate transaction and carries no market view.

9. Verdict, kill-criteria and flip conditions

Buy — Tactical.

The arithmetic and the evidence point the same way, and we are going to say so rather than hide behind the chart. At $41.53 NIKE trades at 19.8x the $2.10 it just delivered and 19.0x the FY2028 consensus of $2.184, holds net cash of approximately $1,085 million on the corrected basis, pays a 3.92% dividend, and just reported a quarter with a 49.2% gross margin and a 12.0% operating margin against 40.3% and 2.9% a year earlier. All four quarters of fiscal 2026 beat consensus and the full year delivered 40.0% above the estimate. Our base of $48 is 15.6% above spot with 3.24:1 asymmetry — and the base does NOT assume the margin recovery, only that the consensus is met and the multiple normalises.

And in April, the chief executive and two directors bought roughly $2.2 million of stock on the open market at $42.27, $42.43 and $43.34. The stock closed today at $41.53.

Five reasons this is Tactical and not Core, each stated as a reservation.

First, nothing on the chart has turned. The stock is 1.9% above its 52-week low, in the 2nd percentile of its annual range, 4.4% below its 50-day average and 23.5% below its 200-day. A 68.6-point twelve-month deficit to the index does not reverse because a valuation looks attractive.

Second, the highest-skill voice in our knowledge base is bearish on this name and has been right for a year, and the bullish claim that names our own insider evidence has been wrong for seven months.

Third, Greater China has fallen 22.5% in two years and is still falling 11.2%. And Footwear — 65.8% of revenue and the core of the brand — declined 1.4% while Apparel grew.

Fourth, capital return is under visible strain. Dividends of $2,407 million exceed free cash flow of $2,184 million, and the buyback has been cut 95% to $146 million. A company that stops repurchasing its own stock at the lowest price in four years is telling you something about its priorities.

Fifth, a new chief financial officer arrives in twelve days, with the outgoing officer separating three weeks later, and incoming chief financial officers commonly re-base guidance downward on arrival.

THE OPERATIVE SIZING DISCIPLINE: a small initial position, scaled on confirmation, with the 2026-09-29 print as the first checkpoint. If the new chief financial officer re-bases fiscal 2027 guidance and the stock trades toward $35 while the gross margin holds above 45%, that is a better entry and the position should be increased, not abandoned. If the gross margin returns below 42%, the thesis is broken and Section 10's kill criteria apply.

Pre-registered KILL criteria — what would take this to Watch or Avoid:

Gross margin below 42% in any quarter, which would make the June quarter a clearance artefact rather than an inflection. This is the primary kill criterion and everything else is secondary.
A dividend cut, which would remove 3.92 points of annual return and would be management's own statement that it does not believe the recovery.
Footwear revenue declining more than 5% in any year, against −1.4% in fiscal 2026.
Greater China falling below $5.0 billion, against $5,847 million.
A sustained break below the 52-week low of $40.75, which is 1.9% away.
Open-market SELLING by Elliott Hill, which would reverse the single strongest piece of evidence in this dive.

Pre-registered UPGRADE conditions — what would take this to Buy — Core:

A second consecutive quarter of gross margin above 45%, which would convert the June quarter from an anomaly into a trend and is the single fact worth more than any other on this name.
Greater China returning to year-on-year growth.
The buyback resuming above $1 billion annualised, which would signal management believes the stock is cheap at these levels and would restore the shareholder yield.
Further open-market purchases by the chief executive or other officers.
The FY2027 consensus being revised above $2.10, i.e. the estimate array catching up to what has already been delivered.

Where NKE sits in the Synthos Framework Portfolio. The consumer sleeve, entering at 1.0% today — deliberately half the usual initial tranche — with a 3% target scaled on either a second quarter of gross margin above 45% or a decline toward $35 with the margin intact. Sizing note, and it is the operative discipline: this is a turnaround in its first confirmed quarter, in a stock that has fallen 77% from its peak and sits 1.9% above its annual low. The correct construction is a position that can be tripled on confirmation, not one that has to be defended on a disappointment. Logged as a tracked Synthos call (Buy — Tactical) as of 2026-08-04 at $41.53, with the fair-value anchors, kill criteria and upgrade conditions all gradeable. The specific thing to grade this dive on is the insider signal: three open-market purchases by a chief executive and two directors, all above the price at which this call is struck.

Single biggest risk: that the June quarter's 49.2% gross margin was clearance, not recovery. The three quarters before it printed 42.2%, 40.6% and 40.2%; the year-earlier comparison was 40.3%. An 890 basis point year-on-year step in a single quarter, in a business emerging from a two-year inventory clean-up, is exactly what the END of discounting looks like — and it is also exactly what a favourable comparison against a heavily-discounted prior quarter looks like. Inventory has been essentially flat at $7.5 billion through the entire decline, which supports the first reading without proving it. The whole investment case is that six points of operating margin are recoverable on a $46 billion revenue base — worth roughly $2.8 billion of operating income and roughly $1.50 per share — and one quarter is one quarter. The 2026-09-29 print is the first opportunity to know, it is 56 days away, and the position is sized accordingly.

Provenance & disclosures

Traceability: 12 name-level knowledge-base claims name NIKE out of 52,021 distilled claims, after five exclusions. Raw hits 17; surviving a case-sensitive entity re-run 17; case-insensitive-only 0; EXCLUDED as quarantine_misattributed 5; breadth 12 across 7 channels; net conviction split. THE DEFECT — the FOURTH name in this batch to show quarantine leakage: five of seventeen claims (29% of the raw lane) sit under quarantine_misattributed, all at skill 2.0. One (2026-05-20, speaker Jordi Visser, bearish 65, entities MCD/NKE/WHR) is a near-verbatim duplicate of the jordi_visser claim of 2026-05-16 at conviction 70 — the SAME duplicate pair already excluded on another name in this batch. The other four (2023-11-29, two on 2023-09-12, 2023-05-11) are web3 and tokenization claims with no identified speaker at skill 2.0. All five excluded; four of the five are bullish, so the exclusion is directionally negative. CLAIMS GRADED: jordi_visser 2026-05-16 (bearish 70, SKILL 2.0) — CORRECT, the stock now sits 1.9% above its 52-week low, down 44.3% over twelve months; gavin_baker 2022-03-25 (bearish 58, speaker Dan Nathan) — DECISIVELY CORRECT, from the $179 referenced to $41.53 is a 76.8% decline, the best-aged claim in this batch; compound_and_friends 2026-01-02 (bullish 55 and 60, the same view stated twice and counted ONCE) — WRONG SO FAR, the stock has fallen 33.2% in the six months since, though the claim's citation of INSIDER BUYING as a bull signal was independently corroborated by this dive from the payload; two darius_dale claims from 2021-07-12 (bullish 60 and 55, skill 0.8) on margin sustainability — COMPREHENSIVELY WRONG, operating margin fell from 15.6% to 8.19% over the following five years. Most surviving claims carry speaker: null; named speakers are Jordi Visser, Dan Nathan and Darius Dale; speaker_role reads independent where present; NO management voice. All quotes are verbatim from the stored claim text.
Data as-of: fundamentals — annual and quarterly statements through 2026-05-31 (fiscal year end) · estimates 2026-08-04 · prices 2026-08-04, quote timestamp 1785873602 = 2026-08-04T20:00:02Z ($41.53, −2.60%; 50-DMA $43.45; 200-DMA $54.30; RSI 44.4; MACD −0.36) · knowledge-base claims 2026-08-04. NIKE's fiscal year ends 31 May. All figures come from the Synthos vendor data file for NKE or from the SEC filings in the NKE archive.
Filing archive contents: 10-K filed 2026-07-15 (fiscal 2026); 10-Q filed 2025-12-30 (November 2025 quarter); 10-Q filed 2026-04-01 (February 2026 quarter); 8-K filed 2026-06-18 (Item 5.02 — the retirement of director John W. Rogers, Jr. effective at the 2026 annual meeting, reducing the board to eleven, with an expected consulting arrangement); 8-K filed 2026-06-23 (Items 2.02 and 5.02 — PRELIMINARY fourth-quarter results pre-announced a week early, together with the appointment of David Denton as Executive Vice President and Chief Financial Officer effective 2026-08-16 and the separation of Matthew Friend on 2026-09-04, with Mr. Denton's compensation disclosed in full: $1,450,000 base, 120% target bonus, $11,500,000 annual long-term incentive target and a $7,250,000 one-time cash award); 8-K filed 2026-06-30 (Item 2.02 — full fourth-quarter and fiscal 2026 results; the release is FURNISHED as Exhibit 99.1 and is not in the extract). Neither earnings exhibit is in this archive, so the June-quarter figures used here come from inc_q and earn_cal.
Where the filings and the arithmetic corrected the vendor (detailed in Section 6): totalDebt of $11,033M, which includes $3,091M of lease obligations — a 28.0% inclusion, the second-largest in this batch — against filed financial debt of $7,942M; netDebt of $3,470M, which omits $1,464M of short-term investments, against NET CASH of approximately $1,085M on the corrected basis, with enterpriseValueTTM of $64,927M overstated by 7.0% against a corrected ~$60,372M and netDebtToEBITDATTM of 0.77x that should be negative; inc_a FY2026 depreciation and amortisation of ZERO against cf_a's $747M, understating inc_a's FY2026 ebitda of $3,953,000,000 by approximately 15.0%, with inc_q reading zero for the June quarter as well; retainedEarnings of EXACTLY ZERO for fiscal 2026, a null rather than a number; the est array, whose FY2026 consensus of $1.49978 sat 40.0% below the delivered $2.10 with all four quarters beating by 80%, 41%, 20% and 555%, and whose FY2027 estimate of $1.731 is BELOW what has already been delivered; and est.ebitdaAvg/ebitAvg, carrying a fixed-ratio signature of exactly 13.09% and 11.72% of revenue in all five forward years. Where vendor and filing AGREED — recorded, because these were directed tests: seg_prod PASSED, summing to $46,398,000,000 against FY2026 revenue to the dollar; seg_geo covers 97.4% of revenue with NORTH AMERICA present at $20,511M (44.2%), the $1,225M gap being Converse and Corporate which NIKE reports outside the four geographic operating segments — an incomplete block with an identifiable gap rather than a corrupt one, so the home-market omission test passes; the capital-expenditure line trips NO corruption signature and capexToDepreciationTTM of 0.911 reconciles to a direct 0.916, with freeCashFlowYieldTTM of 3.554% reconciling exactly to our recomputation; and km_ttm and ratios_ttm are present and complete.
Basis note: NIKE reports on a GAAP basis and the earn_cal actuals track inc_q closely (the June quarter reads $0.72 in both), so no adjusted-versus-GAAP bridge is applied and all multiples are GAAP-to-GAAP. The critical caveat is the STALENESS of the estimate array rather than its basis: consensus was 40.0% below the delivered fiscal 2026 figure, so every forward multiple in this dive is quoted with that caveat attached, and the fair-value anchors are cross-checked against the delivered $2.10 as well as against the FY2028 estimate. Free cash flow is recomputed as filed operating cash flow minus filed capital expenditure.
Estimate coverage: 25 analysts on FY2028 EPS — the anchor for all three fair values — with a range of $1.57998 to $3.7176, a 98% spread, the widest in this batch and an honest reflection of genuine disagreement about whether this is a cyclical trough or a structural decline. 26 on FY2026 (which they got 40% wrong), 24 on FY2027, 13 on FY2029, 5 on FY2030. 71 analysts cover the stock in the grades block — the widest coverage in this batch — with 31 at hold and 5 at sell.
Peer note: the vendor peer set — Amer Sports, ASICS, Deckers, Lululemon, On Holding, Puma, Skechers, Under Armour and V.F. — is the best-constructed peer set in this batch and contains every relevant competitor, several of which have taken share from NIKE over the period of its decline. But no earnings or estimate data for any peer is present in this file, only price and market capitalisation, so no peer-multiple comparison is drawn — which on this name is a genuine limitation, because relative valuation against On Holding and Deckers would materially inform the structural-versus-cyclical question.
Fair-value caveat: the $30 / $48 / $79 anchors are built on the FY2028 consensus EPS distribution (19.0x the low of $1.57998, 22.0x the mean of $2.18409, and for the bull the 52-week high of $79.17, equivalent to 21.3x the high of $3.7176 or 25.3x a margin-recovery case of roughly $3.12), cross-checked against the delivered fiscal 2026 EPS of $2.10 and the observed twelve-month multiple range of 19.4x to 37.7x on it. Stated arithmetic, not a discounted cash flow. The BASE DOES NOT ASSUME THE MARGIN RECOVERY — only that the consensus estimate is met and the multiple normalises to the middle of its own twelve-month band. The margin recovery is the bull case, and if the operating margin returns to the fiscal 2024 level of 12.3% on flat revenue, earnings are roughly $3.12 and 22x gives $69.
Timing: fourth-quarter and full-year fiscal 2026 results were released 2026-06-30, thirty-five days before this dive, with EPS of $0.72 against a $0.11 consensus — a 555% beat — and a 49.2% gross margin against 40.3%. A chief financial officer transition takes effect 2026-08-16, TWELVE DAYS AWAY, with the outgoing officer separating 2026-09-04. The next print is 2026-09-29, 56 days away, against a consensus of $0.43 and $11,380,660K. The insider file's three open-market PURCHASES are dated 2026-04-09, 2026-04-10 and 2026-04-13 at $43.34, $42.43 and $42.27 — all above today's close of $41.53 — and the one open-market SALE is dated 2026-06-12 at $46.18 by the Chief Innovation, Product and Design Officer. 2026-08-04 carried no company-specific SEC filing.
Accessibility note: no information in this dive is conveyed by colour. All emphasis is carried by bold text, table structure and explicit labelling.
Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
Version: 2026-08-04-full.